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Optogenetic inhibition of the electrical activity of neurons enables the causal assessment of their
contributions to brain functions. Red light penetrates deeper into tissue than other visible
wavelengths. We present a red-shifted cruxhalorhodopsin, Jaws, derived from Haloarcula
(Halobacterium) salinarum (strain Shark) and engineered to result in red light–induced
photocurrents three times those of earlier silencers. Jaws exhibits robust inhibition of sensory-
evoked neural activity in the cortex and results in strong light responses when used in retinas of
retinitis pigmentosa model mice. We also demonstrate that Jaws can noninvasively mediate
transcranial optical inhibition of neurons deep in the brains of awake mice. The noninvasive
optogenetic inhibition opened up by Jaws enables a variety of important neuroscience experiments
and offers a powerful general-use chloride pump for basic and applied neuroscience.
Optogenetic inhibition, the use of light-activated ion pumps to enable transient activity
suppression of genetically targeted neurons by pulses of light1–3, is valuable for the causal
parsing of neural circuit component contributions to brain functions and behaviors. A major
limit to the utility of optogenetic inhibition is the addressable quantity of neural tissue.
Previous optogenetic hyperpolarizing proton pumps (Arch1, ArchT3, Mac1) and chloride
pumps (eNpHR4, eNpHR3.0 (ref. 2)) have successfully inhibited volumes of approximately
a cubic millimeter, but many neuroscience questions require the ability to suppress larger
tissue volumes. A number of pharmacogenetic, chemical and genetic strategies have been
used for this purpose5–7, but it would ideally be possible to address these large brain
volumes with the millisecond temporal precision of optogenetic tools.
Another common desire in optogenetic experiments is to minimize invasiveness from
inserting optical fibers into the brain, which displaces brain tissue and can lead to side
effects such as brain lesion, neural morphology changes, glial inflammation and motility, or
compromise of asepsis8–10. Less invasive strategies that do not require an implanted optical
device would also increase experimental convenience and enable longer timescale
experiments than often feasible with fragile implants. While a number of previous studies
using channelrhodopsins have attempted to address this problem11–16, noninvasive optical
inhibition has not yet been possible.
To enable noninvasive large-volume optogenetic inhibition, we engineered and
characterized Jaws, a spectrally shifted cruxhalorhodopsin derived from the species H.
salinarum (strain Shark)17, which mediates strong red light–driven neural inhibition. Jaws is
capable of powerful optical hyperpolarization in a variety of neuroscientific contexts: it
successfully enabled suppression of visually evoked neural activity in mice, functioned in
cone photoreceptors to restore greater light sensitivity in mouse models than possible with
previous opsins and enabled the noninvasive transcranial inhibition of neurons in brain
structures up to 3 mm deep. This new reagent thus makes a variety of important experiments
amenable to optogenetic investigation.
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RESULTS
Engineering a red light–sensitive chloride pump
In earlier work, we identified two cruxhalorhodopsins from the haloarcula H. marismortui
and H. vallismortis that possessed the most red-shifted action spectra known for any
hyperpolarizing opsins1,18. While their low photocurrents made them poor candidates for in
vivo use1, their spectra suggested they might be good scaffolds for further engineering.
Because red light is less absorbed by hemoglobin than blue, green or yellow wavelengths,
we reasoned this red-light sensitivity might render deep brain regions more accessible. We
validated this through Monte Carlo modeling and direct measurement in the live mouse
brain (Supplementary Fig. 1).
We therefore screened members of the cruxhalorhodopsin class in primary neuronal culture
to identify molecules with both red-shifted action spectra and robust photocurrents (Fig. 1a
and Supplementary Fig. 2) and identified a hyperpolarizer we named Halo57, the
cruxhalorhodopsin from H. salinarum (strain Shark), with less than 60% homology to the
Natronomonas pharaonis halorhodopsin (NpHR/halo; Supplementary Fig. 3a). We
subsequently engineered Halo57 by identifying K200R and W214F point mutations19,20
(Fig. 1b), which significantly boosted photocurrents without altering its red action spectrum
(n = 9 or 10 cells; P = 0.02, ANOVA with Dunnett’s post hoc test), and by appending the
KGC21 or ER2 (ref. 22) trafficking sequences from the potassium channel Kir2.1 to result in
the final molecules Jaws (KGC + ER2) and Jaws-ER2 (ER2) (Fig. 1c and Supplementary
Fig. 3b). In accord with the low sequence conservation, the two homologous point mutations
did not enhance the N. pharaonis halorhodopsin (Supplementary Fig. 3a,c,d). Ion-specific
solutions confirmed Jaws to be a light-driven chloride pump (Supplementary Fig. 3e,f).
In vivo optogenetic inhibition has previously only been possible with blue, green and yellow
light, as existing optogenetic inhibitors operate at only 10–30% of their peak capacity at red
wavelengths. Because Jaws has a 14-nm red shift relative to the N. pharaonis halorhodopsin
(NpHR/halo, eNpHR, eNpHR3.0), we hypothesized that it might be a good candidate for
potent red-light neural inhibition (Fig. 1d,e). To further characterize this, we transfected
Jaws, eNpHR3.0 or ArchT into primary neuron cultures along with a secondary cytosolic
tdTomato plasmid and selected cells for whole-cell patch clamp characterization solely on
the basis of the presence of tdTomato (Supplementary Fig. 4), to prevent selection bias for
opsin expression levels and more accurately represent the full range of in vivo expression:
we found Jaws to have significantly higher red light (632 nm) photocurrents than eNpHR3.0
or ArchT across all tested light powers (Fig. 1f and Supplementary Fig. 4d; n = 21–30 cells
from 2 batches of culture; P < 0.01 for 0.1–20 mW/mm2, ANOVA with Newman-Keuls
post hoc test). The robust in vitro photocurrents we observed seemed promising, so we next
moved to assess Jaws in a variety of in vivo contexts.
Potential for optogenetic visual therapeutics
Optogenetic neural hyperpolarization is being explored not only as a tool for basic
neuroscience, but also as a prototype therapeutic. As one example, retinitis pigmentosa is a
visual disorder that results first in night blindness and then in overall blindness as a result of
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photoreceptor degeneration23. A potential therapy for patients with cone photoreceptor
atrophy would be to resensitize the cone cells to light by genetically expressing light-
activated hyperpolarizing ion pumps in the cone photoreceptors, which in their healthy state
hyperpolarize in response to optical stimulation.
When expressed in retinal cones of retinitis pigmentosa mouse models, eNpHR has
previously been shown to be capable of transducing spikes in downstream retinal ganglion
cells and mediating visually guided behaviors. However, the resultant spiking rates are
limited to less than 200 Hz, substantially less than the full wild-type range of 15–450 Hz
(ref. 24), and thus potentially limit fine visual perception in future clinical use. Additionally,
while eNpHR can be activated using light powers that are safe for human use24, more light-
sensitive hyperpolarizers would require less light for stimulation and thus provide a greater
margin of efficacy and safety given the inevitable unknowns that might crop up in potential
future trials in humans. Thus, better neural hyperpolarizers remain of great interest for
potential clinical use in the human eye.
We decided to first compare Jaws’s performance against those of other known
hyperpolarizers by injecting adeno-associated virus (AAV), serotype 8 (AAV8), encoding
various light-driven proton or chloride pumps into the cone photoreceptors of Pde6brd1
mice, also called fast retinal degeneration mice24,25 (Fig. 2a and Supplementary Fig. 5b),
which are blind by postnatal day (P) 28. We conducted extracellular retinal ganglion cell
recordings (Fig. 2b) 4–6 weeks after injection (P64–75) and found peak wavelength
photostimulation of Jaws-expressing photoreceptors to induce significantly more retinal
ganglion spiking, indicated by mean spiking frequencies greater than those for eNpHR,
ArchT, Mac or the wild-type Halo57 (Fig. 2c and Supplementary Fig. 5a). Jaws also enabled
a broader peak spike frequency distribution than other opsins (P < 0.05 for Jaws versus all
other opsins, Kolmogorov-Smirnov test), with a mean frequency of 67.8 ± 7.0 Hz with
eNpHR versus 189.5 ± 15.9 Hz with Jaws (values throughout are mean ± s.e.m. unless
otherwise stated), increasing the spiking bandwidth by threefold (Fig. 2d). We additionally
observed Jaws to mediate the highest ganglion spiking rates over various irradiances of 600
nm, 550 nm and 470 nm light (Fig. 2e and Supplementary Fig. 5c,d), indicating its high light
sensitivity, which alongside Jaws’s spectral peak at 600 nm may confer benefits because of
the relative safety of 600-nm light26. From this comparison of light-sensitive
hyperpolarizers, we conclude that Jaws may represent an optogenetic reagent with molecular
properties better suited than previous opsins for therapeutic cone reactivation for a subset of
patients with retinitis pigmentosa.
In vivo suppression of visually evoked cortical activity
We next evaluated the performance of Jaws in a common neuroscientific experimental
context: the suppression of stimulus-evoked neural activity. Given the proximity of yellow
light to all existing inhibitory opsins’ peak excitation wavelengths1,2, we decided, for this
specific experiment, to directly compare Jaws’s in vivo performance in the mouse brain
against that of other inhibitors, using yellow light. Although all previous studies
characterizing optogenetic hyperpolarizers have focused on inhibiting spontaneous neural
activity1–4, many neuroscientific questions focus on stimulus-evoked or event-associated
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neural activity. The ability to suppress the activity of a given cell type responding to
behaviorally relevant inputs is therefore critical.
To assess Jaws’s potential as a general-purpose inhibitor of stimulus-evoked neural activity,
we injected a Cre recombinase–dependent AAV, serotype 5 (AAV5-FLEX), expressing
eNpHR, eNpHR3.0, Arch, ArchT or Jaws into the primary visual cortex of Emx1-cre
transgenic mice and delivered visual stimuli while delivering yellow light with an optetrode
(593 nm; 35 mW/mm2 out of a 200 µm fiber tip). Inhibition of visually evoked neural
activity was strong (Fig. 3a,b), with an 86 ± 3% reduction of visually evoked activity in
Jaws-expressing cortex (Fig. 3c; from 4 mice, n = 27 units with a significant reduction in
firing; n = 3 units showed no change and n = 3 units showed a significant increase in firing)
over a range of evoked firing rates (1.8–12.5 Hz; Supplementary Fig. 6a), and consistent
across a range of input contrast strengths (Fig. 3d). This comparison of neural inhibitors thus
reveals that Jaws is capable of mediating excellent inhibition of evoked neural activity in a
biologically meaningful context.
A rebound burst of action potentials is common after illumination of cells expressing
halorhodopsins18,27–30 or archaerhodopsins18,27,31, which respectively pump chloride
inward and protons outward. A variety of possible mechanisms have been proposed,
including hyperpolarization-activated Ih currents29,30,32 or changes in chloride reversal
potential due to intracellular chloride accumulation33. We similarly observed post-
illumination rebound in Jaws-, eNpHR3.0- and ArchT-transduced neurons, and Jaws
produced greater effects than eNpHR3.0 or ArchT (Fig. 3e; n = 8–32 units; P < 0.05,
ANOVA with Newman-Keuls post hoc test). We attempted to ameliorate this by gradually
ramping down illumination over a duration of 200–1,000 ms and found that the mean
rebound instantaneous firing rate dropped significantly, from 52 ± 12 Hz to 23 ± 6 Hz (n =
16 units; P = 0.0065, paired t-test), suggesting that sculpting of light pulses may enable
rebound reduction. Notably, the rebound delay also significantly lengthened, from 18 ± 6 ms
to 76 ± 6 ms (n = 16 units; P < 0.001, paired t-test) and became more temporally dispersed
(Fig. 3f–h and Supplementary Fig. 6b). Like all previous inhibitors, Jaws does yield post-
illumination rebound, which likely has implications for careful experiment design
comparable to those for earlier inhibitors such as eNpHR3.0. Further attention to light-pulse
shape may be merited as a way to reduce rebound for all optogenetic inhibitors.
Red-light performance of Jaws
We next assessed Jaws’s red-light properties via whole-cell patch-clamp recordings in acute
cortical slices, as well as extracellular recordings in awake, head-fixed mice. We injected
AAV8 encoding Jaws under the Ca2+/calmodulin-dependent protein kinase (Camk2a)
promoter or a truncated human synapsin (SYN1) promoter, hereafter referred to as hSyn16, or
Jaws-ER2 under the hSyn promoter, into motor cortex and observed robust red light
photocurrents, hyperpolarization and neural inhibition (Fig. 4a–c and Supplementary Fig.
7a,c), with ~95% reduction of neural activity achievable in neurons illuminated by a 200-µm
fiber (130 mW/mm2 fiber tip irradiance at 635 nm; Supplementary Fig. 8). Jaws’s kinetic
properties were comparable to those of other optogenetic inhibitors (Supplementary Fig. 4e
and 7c), and its expression did not alter basal cell properties in cultured cortical neurons
Chuong et al. Page 5
Nat Neurosci. Author manuscript; available in PMC 2014 October 03.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
(Supplementary Fig. 4g), or in cortical or dentate granule neurons in acute brain slice
(Supplementary Fig. 7d and 9).
Having established Jaws as a potent red-light-drivable inhibitor, we next assessed its in vivo
performance compared to that of eNpHR3.0. We did titer-matched injections of 2 × 109 viral
particles of AAV8-hSyn-Jaws, AAV8-hSyn-Jaws-ER2 or AAV8-hSyn-eNpHR3.0 into
mouse motor cortex (Fig. 4d) and performed awake head-fixed recordings to characterize
each hyperpolarizer over different red (637-nm) light powers (Fig. 4e). Yellow light (593
nm) was used as a positive control to identify opsin-expressing neurons, owing to its
proximity to both Jaws’s and eNpHR3.0’s spectral peaks, and we conducted paired
recordings of individual opsin-expressing neurons to assess their performance under
different wavelengths (Fig. 4f ). As expected, both Jaws variants robustly inhibited
spontaneous neural activity when illuminated with either red (88.8 ± 15.9% inhibition for
Jaws, 97.2 ± 3.9% inhibition for Jaws-ER2) or yellow wavelengths (94.2 ± 9.3% inhibition
for Jaws, 99.0 ± 1.6% inhibition for Jaws-ER2), while eNpHR3.0’s red-light inhibition
dropped significantly to only 27.5 ± 30.3% relative to its peak yellow-light performance of
76.1 ± 11.1% inhibition (Fig. 4f; n = 5 or 6 units, P = 0.0121), and we found these red-light
results to hold over a range of firing rates (Fig. 4g; n = 5–8 units for each opsin).
Noninvasive optogenetic inhibition
Having demonstrated Jaws’s efficacy as a red-light-drivable reagent in a variety of contexts,
we next sought to determine its potency as a noninvasive and long-distance neural inhibitor.
Using red illumination (Fig. 5a), we found we could transdurally inhibit neurons in the
medial prefrontal cortex of a mouse, with a 86 ± 13% decrease (mean ± s.d.) in firing for
neurons showing suppression (n = 66 units across 2 anesthetized mice; Fig. 5d). Using a
similar strategy, we successfully inhibited neurons in the awake mouse cortex by delivering
red light transcranially through the intact skull (635 nm, 10 mW/mm2 out of a 1,500 µm
fiber tip; Fig. 5a,b) to regions 1–3 mm below the brain’s surface (Fig. 5c,e,f). Transcranial
inhibition in the motor, somatosensory, insular and piriform cortices was efficient, with a 92
± 14% decrease in firing for neurons showing suppression (mean ± s.d.; from 7 mice, n = 13
units; n = 9 units showed no change and n = 3 units showed an increase in activity; Fig. 5f).
The efficacy of transcranial optogenetic inhibition was similar across several millimeters of
the awake mouse brain (Fig. 5g) and over a variety of baseline firing rates (Fig. 5h). To
directly address the possibility that opsin-expressing apical dendrites near the brain’s surface
were being hyperpolarized, resulting in somatic or downstream network inhibition, we next
conducted paired recordings using a standard acutely inserted 200-µm fiber as a positive
control for transcranial illumination outside the mouse’s intact skull. Illumination from a
200-µm fiber has been shown to fall off rapidly within a few hundred microns of the fiber
tip34,35, and the likelihood of optogenetic inhibition has been similarly demonstrated to fall
off over a similar distance31. Our paired recordings revealed similar degrees of suppression
over a range of 1–3 mm below the brain’s surface (Fig. 5i,j). From this, we conclude Jaws is
capable of noninvasive optogenetic inhibition comparable to the current standard of invasive
optical delivery.
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DISCUSSION
We here report Jaws, a red light sensitive opsin with the most red-shifted spectrum of any
optogenetic inhibitor known to us. Jaws enabled efficacious transcranial inhibition of neural
activity in awake mouse brain in response to red light, with a similar efficacy to standard
invasive light delivery with a 200-µm optical fiber. Additionally, Jaws enabled significantly
more inhibition of stimulus-evoked neural activity than possible with previous
halorhodopsins. Finally, it restored photosensory responses in retinitis pigmentosa retinas in
a fashion achieving greater spike rates than previously achievable and with a more
naturalistic frequency range, which may be important for retinal neural coding. Thus, Jaws
has demonstrated utility across a wide variety of key neuroscience applications, both basic
science and preclinical. We also demonstrate that light pulse sculpting can ameliorate the
amplitude of the post-inhibition rebound that has been widely reported for optogenetic
inhibitors.
It has been previously well established that optical penetrance of mammalian tissues in the
red to near-infrared (600–1,000 nm) wavelengths is better than that of bluer wavelengths, as
a result of substantially less absorption from hemoglobin, myoglobin and lipid. Despite this
better red light penetrance, however, myelination may still affect optical propagation in
neural tissue and should therefore be taken into account given the experimental system in
question36,37. The relative inexpensiveness and stability of red light sources may
additionally be of use to experimental investigators, as well as the ability to avoid potentially
confounding experimental visual artifacts, since mouse visual pigments peak at
approximately 380 nm (ultraviolet cones) and 500 nm (green cones), but mouse vision
above 600 nm is poor38,39.
As others have reported, we observed a small number of neurons across multiple in vivo
experiments that increased firing during optical illumination delivered either transcranially
or from a 200-µm fiber, most likely as a result of network inhibition from upstream
neurons3,40,41. It is not possible to noninvasively illuminate only deep volumes with our
experimental setup without also targeting surface and intermediate layers. We therefore
cannot explicitly rule out the possibility that the observed noninvasive results were the result
of indirect network activity or apical dendritic illumination: a caveat for any in vivo
investigation of noninvasive optogenetics. However, the robust photocurrents we observed
both in vitro and in acute slices over a range of irradiances are consistent with and
corroborate the functional inhibition we observed in vivo in awake mice. We therefore
believe our paired recordings comparing transcranial illumination with local 200-µm fiber
illumination to be highly suggestive of direct inhibition.
In scenarios where brain integrity is mandatory, noninvasive optogenetics may be invaluable
in helping to prevent the many known issues associated with implants8–10. The efficacy and
simplicity of transcranial inhibition could be helpful for chronic optogenetic experiments
involving long-term imaging42,43, longitudinal monitoring of disease progression44, or
developmental studies, during which developmental changes in brain structures might
preclude the chronic implantation of a fiber at a given target45. In principle, the need for
brain surgery could be eliminated altogether by using transcranial illumination with a Jaws-
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expressing transgenic mouse strain27. Neural inhibition in animals with large brains, such as
the rhesus macaque, in which perturbation of behavior with optogenetic stimulation or
inhibition of neurons has recently been demonstrated46,47, may particularly benefit from the
use of Jaws. Finally, with increasing interest in the potential for therapeutic
optogenetics24,48, the opsin described here may prove useful in the context of the many
prototype therapies being explored.
ONLINE METHODS
Animal procedures
All procedures were in accordance with the National Institute for Laboratory Animal
Research Guide for the Care and Use of Laboratory Animals and approved by the Boston
University Institute Institutional Care and Use Committee (for extracellular red light
experiments conducted transcranially or with a 200 um fiber), the Massachusetts Institute of
Technology Committee on Animal Care (for all in vitro experiments, slice electrophysiology
and light propagation measurements) or the Yale University Institute Institutional Care and
Use Committee (for inhibition of evoked response and transdural red light experiments). The
Swiss Veterinary Office approved all animal experiments and procedures for viral delivery
of opto-genes and multi-electrode array recordings (for the retina experiments). All mice in
this study were housed 3–5 per cage, maintained with a 12-h light-dark cycle, and had no
previous experimental history.
Plasmid construction and site directed mutagenesis
Opsin genes were mammalian codon–optimized and synthesized (Genscript). Point mutants
were generated using the QuikChange kit (Stratagene) on the opsin-GFP fusion cassette in
the pEGFP-N3 backbone (Invitrogen). Cultured neuron experiments were carried out by
subcloning all genes into a lentiviral backbone containing the Camk2a promoter and with a
C-terminal GFP fusion. AAV vectors were constructed by subcloning opsin-GFP cassettes
into AAV vectors behind the Camk2a, CAG or hSyn truncated human synapsin (SYN1)
promoters. For cone photoreceptor delivery, opsin-GFP cassettes were subcloned into
pAAV2-mCAR-EGFP, replacing the EGFP gene24.
All constructs were verified by sequencing, and codon-optimized sequences were submitted
to GenBank (accession codes KM000925, KM000926, KM000927 and KM000928) and
made available at http://syntheticneurobiology.org/protocols/.
In vitro culture, transfection and imaging
Hippocampal neuron cultures were prepared from postnatal day 0 or 1 Swiss Webster mice
(Taconic), plated at a density of 16,000–20,000 per glass coverslip coated with Matrigel
(BD Biosciences)51, and transfected at 3–5 d in vitro (DIV) using calcium phosphate
(Invitrogen)1,3. GFP fluorescence was used to identify transfected neurons for the
cruxhalorhodopsin screen and HEK293FT characterizations; all other experiments were
conducted by cotransfecting with an independent tdTomato plasmid, in which case neurons
were picked based solely on tdTomato fluorescence.
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Whole cell patch clamp recordings were made using a Multiclamp 700B, a Digidata 1440
and a PC running pClamp (Molecular Devices). Neurons were recorded 14–24 DIV, bathed
in room temperature Tyrode’s solution containing 125 mM NaCl, 2 mM KCl, 3 mM CaCl2,
1 mM MgCl2, 10 mM HEPES, 30 mM glucose, 0.01 mM NBQX and 0.01 mM GABAzine
(Sigma) at pH 7.3 (NaOH-adjusted) and osmolarity 300 mOsm (sucrose-adjusted). HEK
cells were bathed in an identical Tyrode’s bath solution lacking GABAzine and NBQX. No
all-trans-retinal was supplemented for any recordings. 3–9 MΩ borosilicate glass pipettes
(Warner Instruments) were pulled with a P-97 micropipette puller (Sutter Instruments) and
filled with a solution containing (in mM) 125 potassium gluconate, 8 NaCl, 0.1 CaCl2, 0.6
MgCl2, 1 EGTA, 10 HEPES, 4 Mg-ATP and 0.4 Na-GTP at pH 7.3 (KOH-adjusted) and
osmolarity 298 mOsm (sucrose-adjusted).
Ion selectivity tests were carried out in chloride-free recording solution containing (in mM)
125 sodium gluconate, 2 potassium gluconate, 3 CaSO4, 1 MgSO4, 10 HEPES, 30 glucose,
at pH 7.3 (NaOH-adjusted) and 305–310 mOsm (sucrose-adjusted), and using intracellular
solution containing (in mM) 125 potassium gluconate, 8 sodium gluconate, 0.1 CaSO4, 0.6
MgSO4, 1 EGTA, 10 HEPES, 4 Mg-ATP, 0.4 Na-GTP, pH 7.3 (KOH-adjusted), 295–300
mOsm (sucrose-adjusted).
No action spectrum data were gathered from cells voltage-clamped at −65 mV with a leak
current greater than −200 pA or with a resting membrane potential more positive than −45
mV in current-clamp mode. Access resistance was 5–30 MΩ. Resting membrane potential
was ~−65 mV for neurons and ~−30 mV for HEK 293FT cells in current-clamp recording.
All parameters were monitored throughout recording.
All in vitro action spectra, photocurrent and voltage data were taken with a Leica
DMI6000B microscope. Action spectra were taken with a monochromator (Till Photonics
Polychrome V, 15 nm bandwidth centered around each value). Spectra for a given cell were
taken by averaging red-to-UV (685 to 387 nm) and UV-to-red (387 to 685 nm) spectra, to
eliminate history dependence. Photon fluxes for all wavelengths were ~3.0 × 1021
photons/s/m2 (0.756 mW/mm2 at 670 nm). Normalized action spectra were obtained by
dividing the averaged photocurrent data by the highest observed data point.
Trafficking in vitro photocurrents were taken with a DG-4 optical switch with 300 W xenon
lamp (Sutter Instruments), delivered with a 575 ± 25 nm bandpass filter (Chroma). All other
in vitro photocurrents were measured using 470 nm, 530 nm or 625 nm LEDs (Thorlabs).
LED spectra were bandpass filtered with the following (Semrock): 530 nm LED with 543
nm ± 11 nm filter or 625 nm LED with 632 nm ± 11 nm. All light powers were measured
out of the objective lens with a PM200B photodetector (Thorlabs). Data were analyzed
using Clampfit (Molecular Devices) and Matlab (MathWorks, Inc.).
AAV preparation
The AAV particles used for cone photoreceptor targeting were produced in the laboratory of
B.R.52, with titers between 5.2 × 1011 and 6.8 × 1012 GC/ml. All other AAV constructs were
produced by the University of North Carolina Chapel Hill Vector Core at a titer of ~6 × 1012
Chuong et al. Page 9
Nat Neurosci. Author manuscript; available in PMC 2014 October 03.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
c.f.u./ml. All viral dilutions were carried out in phosphate-buffered saline (PBS; Life
Technologies).
In vivo rodent electrophysiology
All light powers were measured and reported at the fiber tip (rather than calculated some
distance away); for example, we measured 4 mW emitted from a 200-µm fiber, which we
calculated and reported as 127 mW/mm2 density out of the fiber tip.
Injections for glass-pipette electrophysiology were made under isoflurane anesthesia and
buprenorphine analgesia, and 1 µl AAV was injected through a craniotomy made in the
mouse skull into the motor cortex (1.78 mm anterior, 1.5 mm lateral and 1.75 mm deep,
relative to bregma) or the piriform, insular or somatosensory/motor cortices (1.78 mm
anterior, 2.0 mm lateral and, respectively, 4.0, 3.0 and 2.0 mm deep, relative to bregma) of
female C57BL6 mice 5–9 weeks old. Comparisons with eNpHR3.0 and Jaws were carried
out by injecting 2 × 109 viral particles in 1 µl of an AAV-PBS mixture into motor cortex.
All viruses were injected at a rate of 0.15 µl/min through a 34-gauge injection needle, after
which the needle was allowed to rest at the injection site for 10 min to allow viral diffusion.
The craniotomy was marked with Examix NDS (GC America), headplates were affixed to
the skull with skull screws (JL Morris), and the craniotomy and headplate were covered with
dental cement (C&B Metabond).
Expression in Jaws-targeted populations of neurons in the prefrontal cortex was achieved by
intracranial injection of AAV8-hSyn-Jaws in P60–120 male C57BL/6 mice. Opsins were
expressed in excitatory neurons in primary visual cortex by injecting AAV5-CAG-FLEX
viruses into Emx1-cre or Pvalb-cre (ref. 53) mice. Mice were anesthetized with 1.5%
isoflurane and virus was injected at 0.1µl/min; mice were given 4–5 weeks for recovery.
Extracellular recordings to measure inhibition of spontaneous neural activity were made in
the cortex of headfixed awake mice 1–2 months after virus injection, using 3–10 MΩ saline-
filled glass microelectrodes containing silver/silver chloride electrodes1,3. Signals were
amplified with a Multiclamp 700B and digitized with a Digidata 1440, using pClamp
software (Molecular Devices). A 635-nm, 200-mW laser (Shanghai Laser Optics and
Century) was coupled to a 200-µm-diameter optical fiber. An optical fiber was attached to
the recording glass electrode, with the tip of the fiber 600 µm laterally from and 500 ± 50
µm above the tip of the electrode, and guided into the brain with a Sutter manipulator.
Transcranial recordings were carried out with a 635-nm red laser coupled to a 1,500-µm-
diameter optical fiber, and the recording electrode was also attached to a 200-µm-diameter
fiber, coupled to a different 635-nm laser, as described above. Comparisons between Jaws
and eNpHR3.0 were carried out using a 593-nm yellow laser (Shanghai Laser Optics and
Century) and a 637-nm red laser (Coherent Lasers), which were both coupled into the same
200-µm-diameter optical fiber. All lasers were controlled via Digidata-generated TTL
pulses. Light powers were measured with an integrating sphere (S142C, Thorlabs) and
PM200B photodetector (Thorlabs).
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In vivo whole cell patching was conducted in the cortex of anesthetized mice with an
autopatcher54. A 200-µm fiber was coupled to a 635-nm red laser, and attached to a patch
electrode as described for extracellular glass pipette recordings. Data were acquired and
analyzed using pClamp software (Molecular Devices).
Extracellular recordings to measure suppression of evoked neural activity were conducted in
mice anesthetized with 0.2–0.4% isoflurane and 0.8 mg/kg fentanyl. Extracellular recordings
were performed with moveable arrays of tetrodes (Thomas Recording) with a 250-µm
interelectrode distance. Data acquisition at 40 kHz and online spike identification by
waveform analysis used Cheetah data acquisition software (Neuralynx). An optical fiber
(200 or 1,500 µm) was placed on the dura next to the electrode array and connected to either
a 593-nm or a 635-nm laser. To activate Jaws, 1-s pulses of light were given at 0.1 Hz at
varying light intensities (10, 25, 50 or 75 mW/mm2). Visually evoked responses were driven
by randomized sequences of drifting gratings at 16 orientations and a spatial frequency of
0.05 cycles/degree on a background of mean luminance. The size of the visual stimulus was
optimized for the receptive fields of the recorded population. Response measurements for
each neuron were taken at the optimal orientation as identified by post hoc analysis.
Data were analyzed using Matlab (MathWorks)1,3. Briefly, spikes were detected and sorted
offline using Offline Sorter (Plexon) or waveform template matching and principal
component analysis discrimination (KlustaKwik and custom-written Igor software,
J.A.C.55). Only clusters with clear refractory periods in the autocorrelogram, indicating a
single-unit source, were used for further analysis. As a further precaution against over-
representation of the same unit, cross-correlograms were run for every pair of identified
units in a set. Clusters that were not easily separable were discarded. Light-modulated units
were identified by performing a paired t-test between the 1- or 5-s illumination period
against the baseline firing period of the same time duration immediately before illumination,
thresholding at P < 0.05. The degree of suppression by Jaws activation was calculated for
each cell by dividing the mean firing rate during the light stimulus by the mean baseline
firing rate during the same time duration before light stimulation onset. Rebound firing rates
were calculated in a window immediately after the cessation of the light stimulus. The width
of the window was determined as the duration for which firing rates were elevated >3 s.d. of
the mean spontaneous firing rate.
Light onset latency to inhibition was calculated by sweeping a 20-ms sliding window to
identify the earliest 20-ms period deviating from the baseline firing rate, as assessed by
performing a paired t-test for the firing rate during each window versus during the baseline
period, averaged across all trials for each neuron. The time for after-light suppression to
recover back to baseline was calculated by taking the median of all trials, owing to a
nonparametric distribution.
Ex vivo slice electrophysiology
For whole-cell patch clamp recordings in motor cortex, coronal 300-µm brain slices were
prepared 4 or 6 weeks after viral injection of AAV8-hSyn-Jaws. Male C57BL6 mice were
deeply anesthetized with sodium pentobarbital (200 mg/kg), then transcardially perfused
with 15–20 ml of ice-cold modified artificial cerebrospinal fluid (ACSF; composition in
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mM: NaCl 87, KCl 2.5, NaH2PO4 1.3, MgCl2 7, NaHCO3 25, sucrose 75, ascorbate 5,
CaCl2 0.5, in ddH2O; osmolarity 320–330 mOsm, pH 7.30–7.40) saturated with carbogen
gas (95% oxygen, 5% carbon dioxide). The brain was rapidly removed from the cranial
cavity and then sectioned using a vibrating-blade microtome (VT1000S, Leica). Slices were
allowed to recover for at least 90 min in a holding chamber containing ACSF (composition
in mM: NaCl 126, KCl 2.5, NaH2PO4 1.25, MgCl2 1, NaHCO3 26, glucose 10, CaCl2 2.4, in
ddH2O; osmolarity 299–301 mOsm; pH 7.35–7.45) saturated with carbogen gas at 32°C
before being transferred to the recording chamber for electrophysiology. Once in the
recording chamber, slices were continuously perfused at a rate of 2 ml/min with fully
oxygenated ACSF at 32 °C with added picrotoxin (100 µM), NBQX (20 µM; Sigma) and
AP5 (50 µM; Tocris) to block fast synaptic transmission in the slice.
For whole-cell patch clamp recordings of dentate granule cells, four male C57BL6 mice 9–
10 weeks old were injected with AAV8-Camk2a-Jaws under deep isoflurane anesthesia. 0.5
µl AAV was delivered twice at two locations into the hippocampus (3.2 mm posterior, 3.1
mm lateral and, respectively, 2.3 and 2.7 mm deep, relative to bregma) at 100 µl/min with a
34-gauge needle attached to a Hamilton 5-µl syringe, and the needle was left in place for 3
min to allow viral diffusion. Four weeks after injection, mice were killed by decapitation
and horizontal 300 µm brain sections were prepared on a Leica VT1200 S vibratome.
Sucrose-based ACSF (composition in mM: sucrose 75, NaCl 67, NaHCO3 26, glucose 25,
KCl 2.5, NaH2PO4 1.25, CaCl2 0.5, MgCl2 7; pH 7.4, osmolarity 305– 310 mOsm) was
used for cutting (at 4 °C) and subsequent storage of slices (32°C for 20–30 min, then
maintenance at room temperature, 23.0–23.5°C). After > 1 h incubation, slices were
transferred to a submerged recording chamber continuously perfused at 2 ml/min with
ACSF (in mM: NaCl 119, NaHCO3 1.24, glucose 10, KCl 2.5, NaH2PO4 1.24, CaCl2 2.5,
MgCl2 1.3, pH 7.4, 295 mOsm) maintained at room temperature. Jaws-infected cells were
identified under 460–480 nm blue light, whereas visual guidance of the patch electrode was
assisted by infrared differential interference contrast (DIC) microscopy (Olympus BX51).
Electrodes for cortical recordings were pulled from thin-walled borosilicate glass capillary
tubing using a P-97 puller (Sutter Instruments) and had resistances of 4–6 MΩ when filled
with internal solution (composition in mM: potassium gluconate 125, NaCl 10, HEPES 20,
Mg-ATP 3, Na-GTP 0.4 and 0.5% biocytin, in ddH20; osmolarity 289 mOsm; pH 7.31).
Capacitance, series resistance and input resistance were frequently measured throughout
recording to monitor cell health. Cells were visualized through a 40× water-immersion
objective on an upright microscope (Scientifica) equipped with infrared DIC optics and a Q-
imaging Retiga Exi camera (Q Imaging).
Tip electrode resistance for dentate granule cell recordings was 4.6–7.4 MΩ in ACSF. Patch
electrode solution consisted of (in mM) potassium gluconate 122.5, KCl 12.5, KOH-HEPES
10, KOH-EGTA 0.2, Mg-ATP 2, Na3-GTP 0.3, NaCl 8 (pH 7.35, mOsm 296), and 0.2–0.4
mg/ml biocytin was added immediately before use. 10-pA step hyperpolarization/
depolarization square current pulses were used to determine the input-output relationship
and 300 pA ramp depolarization was used for AP generation. Uninfected dentate granule
cells recorded from the contralateral dentate gyrus of virus-injected mice or uninjected
animals served as controls. None of these cells responded to 625-nm red light.
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Uncompensated series resistance was typically 14–25 MΩ, and cells with resting membrane
potential more positive than −50mV were discarded (n = 3).
Optical activation was delivered to motor cortex using 500-ms pulses from 590-nm or 625-
nm LEDs (Thorlabs), which were additionally filtered with bandpass filters (Semrock): 590-
nm LED with 590-nm ± 10-nm filter or 625 nm LED with 632-nm ± 11-nm filter, and to
dentate granule cells using 1 s 625-nm red light (M625L3-C1, ThorLabs, 68 mW/mm2). All
light powers were measured out of the objective lens with a PM200B photometer
(Thorlabs). Illumination spot sizes were measured by photobleaching an in-focus
microscope slide coated with Alexa 488 dye for 10 min under full-intensity illumination,
then imaging with a micrometer calibration slide to determine the photobleached radius.
All recordings were made using a Multiclamp 700B amplifier and Clampex 10 or 10.4
software (Molecular Devices, CA, USA). Cortical recordings were low-pass filtered at 1 Hz
and digitized at 10 kHz using a Digidata 1550 (Molecular Devices, CA, USA); dentate
granule cell recordings were digitized with a Digidata 1440. All data were analyzed using
Clampfit (Molecular Devices) and Matlab (MathWorks).
Retinal multi-electrode array recordings
Rodent information is outlined in Supplementary table 1. Experiments were conducted as
previously described24. Briefly, for viral injections to the retina, animals were anesthetized
using 3% isoflurane. A small incision was made with a sharp 30-gauge needle in the sclera
near the lens and 2 µl AAV particles were injected slowly into the subretinal space using a
blunt 5-µl Hamilton syringe held in a micromanipulator.
To record spike trains from retinal ganglion cells, isolated mouse retinas were placed on a
flat MEA60 200 Pt GND array (30-µm-diameter microelectrodes spaced 200 µm apart)
(Ayanda Biosystems or Multi Channel Systems). The retina was continuously superfused in
oxygenated Ringer’s solution (110 mM NaCl, 2.5 mM KCl, 1.0 mM CaCl2, 1.6 mM MgCl2,
22 mM NaHCO3 and 10 mM d-glucose (pH 7.4 with 95% O2/5% CO2)) at 36 °C during
experiments. Signals were recorded (MEA1060-2-BC, Multi-Channel Systems) and filtered
between 500 Hz (low cut-off) and 3,500 Hz (high cut-off). Action potentials were extracted
with a threshold of greater than 4 times the s.d. of the recorded trace (Matlab, MathWorks).
Histology
We performed histology on n = 6 mice injected with AAV8-hSyn-Jaws, n = 2 mice injected
with AAV8-hSyn-eNpHR3.0 and n = 2 mice injected with AAV8-hSyn-Jaws-ER2,
representative images from each of which are shown in Figures 4 and 5. We examined n = 7
opsin-expressing retinas, and the images shown in Figure 2 and Supplementary Figure 5 are
representative of the whole population.
Mice were terminally anesthetized with isoflurane, then perfused through the left cardiac
ventricle with 4% paraformaldehyde in PBS. The brain was removed and sectioned into 40
µm coronal sections on a cryostat and subsequently mounted with Vectashield HardSet
(Vector Labs). Acute brain slices were fixed in 4% paraformaldehyde overnight at 4 °C after
recording and then washed in PBS. The slices were blocked for 1 h at room temperature in
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PBS containing 3% normal donkey serum (NDS) and 0.3% Triton, followed by incubation
with Alexa 405-conjugated streptavidin (1:1,000; Life Technologies) in PBS containing 3%
NDS and 0.3% Triton, for 2 h at room temperature, to reveal biocytin labeling. Brain slices
were subsequently washed in PBS, mounted on glass slides and coverslipped with PVA-
DABCO (Sigma).
Cryosectioned slides were visualized and imaged with a Zeiss LSM 510 confocal
microscope using 20× and 63× objective lenses, or a Nikon TI-E microscope using a 20×
objective lens. Acute slices were imaged using a Olympus FV1000 confocal laser scanning
microscope through a 10×, 0.40 numerical aperture objective or a 40×, 1.30 numerical
aperture oil-immersion objective using Fluoview software (Olympus). Images were
subsequently processed in Adobe Photoshop CS6 (Adobe Systems).
Retinal immunostaining was conducted as previously described24. Briefly, retinas were
isolated and fixed in 4% paraformaldehyde in PBS for 30 min at room temperature, and
washed in PBS overnight at 4 °C. Retinal whole mounts were incubated in 30% sucrose
treated with three freeze-thaw cycles, after which all steps were performed at room
temperature. Retinas were incubated in a blocking solution (10% normal donkey serum
(NDS, Chemicon), 1% bovine serum albumin (BSA) and 0.5% Triton X-100 in PBS, pH
7.4) for 1 h. Primary and secondary antibody applications were done in 3% NDS, 1% BSA,
0.02% sodium azide and 0.5% Triton X-100 in PBS.
Primary antibodies for GFP (rat-GFP, 1:500, Nacalai/Brunschwig 04404-84) and mCAR
(rabbit-cone-arrestin, 1:200, Millipore AB15282) were applied for 3 d. After washing the
retina three times for 10 min in PBS, the retina was incubated with cyanine dye-conjugated
secondary antibodies (1:200; donkey anti-rat–Cy5, Jackson Labs 712–175-153, or donkey
anti-rabbit–Cy3, Jackson Labs 711-165-152) and 10 µg/ml DAPI (Roche Diagnostics) for 2
h. After another three 10-min washes in PBS, the retina was mounted on a glass slide with
ProLong Gold antifade reagent (Invitrogen). Confocal images of antibody-stained retinas
were taken using a Axio Imager Z2 equipped with a LSM 700 scanning head.
In vivo light propagation measurements and Monte Carlo modeling
Isotropic light measurement probes were constructed by gluing a 300-µm-diameter spherical
ruby ball lens to the end of a 400-µm-diameter multimode optical fiber with transparent,
UV-cured adhesive. Emitted fluorescence was measured using an HR2000 CCD
spectrometer (Ocean Optics) and recorded using SpectraSuite (Ocean Optics). Prior to
testing, a dark spectrum measurement was taken and a nonlinearity correction was applied
using default coefficients. The probe was calibrated in water (n = 1.33) with collimated
light.
532- or 635-nm lasers (Shanghai Laser Optics Company) were connected to an optical
shutter via a 200-µm-diameter multimode fiber, and the shutter was FC-coupled to a 1.5-
mm-diameter plastic optical fiber. Five male C57BL/6J mice were used for green light
measurements and five different C57BL/6J mice were used for red light measurements. All
measurements were taken under pentobarbital analgesia (50 mg/kg, i.p.). Of the 10 mice × 3
depths × 5 powers, one mouse was not analyzed because the 3-mm-depth files were
Chuong et al. Page 14
Nat Neurosci. Author manuscript; available in PMC 2014 October 03.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
inadvertently not saved owing to manual save process clunkiness; 6 other files were also
inadvertently not saved, but at least 3 power levels were measured for every depth and
mouse other than the one noted above.
In Matlab, we performed Monte Carlo simulations of light scattering and absorption in the
brain from light emitted from the end of an optical fiber by dividing a cube of gray matter
into a 100 × 100 × 100 grid of voxels, each voxel 50 µm × 50 µm × 50 µm in dimension,
using previously published algorithms56,57. To achieve accurate simulations of light
propagation close to the optical fiber, before the orientation of photon trajectories is
randomized by multiple scattering events, we used an anisotropic scattering model with
either Henyey-Greenstein or Gegenbauer kernel phase functions, as indicated below. We
interpolated data from ref. 58 to obtain scattering coefficients for gray matter and white
matter at wavelengths of 532 and 635 nm (below). Because ref. 58 used samples washed of
blood, the effects of blood on optical properties of these tissues would not be reflected in
their measurements; to accurately simulate in vivo conditions, the effects of blood scattering
must be added. We took the brain’s blood volume fraction to be 4% (ref. 59) and the red cell
volume fraction of blood (hematocrit) to be 45% (ref. 60). Thus, excluding large blood
vessels, the brain contains dilute blood that has about a 1.8% hematocrit. In this red blood
cell concentration regime, the anisotropy coefficient is constant and the scattering and
absorbing coefficients are directly proportional to hematocrit61. To calculate the total
scattering coefficient, we added the scattering coefficient due to brain tissue alone to the
scattering coefficient due to the blood in the tissue. To calculate the total absorption
coefficient, we likewise added the absorption coefficient due to brain tissue alone to the
absorption coefficient due to the blood in the tissue. To calculate the anisotropy coefficient,
we took the weighted average anisotropy coefficients of the tissue and blood, weighted by
the relative likelihood of each of the two components of causing a scattering event. We
chose the Gegenbauer kernel for the phase function when blood was present, as blood is a
large component of the scattering and has been shown to be modeled well using that phase
function61. With no blood present, as was assumed for the bone, we used the Henyey-
Greenstein phase function as in ref. 58. Optical properties of bone at 532 nm and 633 nm
were interpolated from data in refs. 62,63.
We used simplified geometries of gray matter and skull bone to illustrate the effects of tissue
variations in several experimental locations. In each case, the tissue properties were set on a
per-voxel basis, with no corrections for specular reflections or refraction at boundaries
between tissue types.
We launched 2 × 106 packets of photons in a fiberlike radiation pattern through fibers
modeled on the experimentally used fiber—1.5 mm diameter, 0.5 NA—and modeled their
propagation into the brain on the basis of the algorithm of ref. 64. In essence, whenever a
photon packet entered a voxel, our program probabilistically calculated the forecasted
traveling distance before the next scattering event. If that traveling distance took the photon
packet out of the starting voxel, then the packet would be partially absorbed appropriately
for the distance it traveled within the voxel and the voxel’s absorption coefficient. The
process would then restart upon entry of the photon packet into the new voxel. If the
distance traveled before scattering was less than the distance to the edge of the voxel, then
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the packet would be partially absorbed appropriately for the distance it traveled within the
starting voxel, and a new direction of packet propagation would be randomly chosen
according to the phase function. Using this model, we generated Supplementary Figure 1a,b,
which shows the contours at which the light fluence falls off to various percentages of the
light intensity emitted by the fiber.
The coefficients we used were as follows:
Gray matter at 532 nm with 4% v/v blood: absorption coefficient (mm−1) 0.942, scattering
coefficient (mm−1) 23.3, anisotropy factor 0.949, using the Gegenbauer kernel phase
function.
Gray matter at 633 nm with 4% blood: absorption coefficient (mm−1) 0.071, scattering
coefficient (mm−1) 20, anisotropy factor 0.95, using the Gegenbauer kernel phase function.
Bone at 532 nm with no blood: absorption coefficient (mm−1) 0.105, scattering coefficient
(mm−1) 34, anisotropy factor 0.93, using the Henyey-Greenstein phase function.
Bone at 633 nm with no blood: absorption coefficient (mm−1) 0.06, scattering coefficient
(mm−1) 33, anisotropy factor 0.93, using the Henyey-Greenstein phase function.
White matter at 532 nm with 4% blood: absorption coefficient (mm−1) 1.0, scattering
coefficient (mm−1) 55.3, anisotropy factor 0.862, using the Gegenbauer kernel phase
function.
White matter at 633 nm with 4% blood: absorption coefficient (mm−1) 0.134, scattering
coefficient (mm−1) 53.8, anisotropy factor 0.87, using the Gegenbauer kernel phase
function.
To measure skull thickness for Supplementary Figure 1a, male C57BL/6 mice were
transcardially perfused with 4% formaldehyde in PBS, and the skulls were removed and
imaged with a Nikon XTH160 X-ray micro-CT system. Images were generated at an X-ray
voltage of 45 kV and a current of 7.5 W. Sixteen frames per projection were acquired with
an integration time of 100 ms, with a total acquisition time of 42 min per skull. Acquired
images were reconstructed with CT Pro 3D (Nikon Metrology) and visualized with
VGStudio 2.0 (Volume Graphics). Coordinates were stereotactically defined relative to
bregma and skull thicknesses determined by measuring z-direction differences at a given
coordinate.
Statistical analysis
No statistical methods were used to predetermine sample sizes, but sample sizes in this
paper were similar to those in previous papers from our group1,3,65,66 and were chosen to
reflect sample sizes that might be experienced by end-users. No blinding was carried out,
with the exception of cotransfected opsin-GFP and tdTomato data sets, as the chief goal of
the paper was to demonstrate the capabilities of a new technology. No randomization was
carried out. All replicates were biological.
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Statistical analyses were performed using JMP Pro 10 (SAS Software) and Prism 5
(GraphPad). All data were tested for normality with a Shapiro-Wilk test. Two-sample
comparisons were characterized with a two-tailed t-test, and multiway comparisons for a
single variable were characterized with an ANOVA followed by a Newman-Keuls multiple
comparison post-test between pairs. Paired tests were conducted with a two-tailed paired
sample t-test. A Kolmogorov-Smirnov test was used to assess differences in spiking
frequency distributions because of its sensitivity to both location and shape of cumulative
distribution functions.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Engineering and in vitro characterization of Jaws, a red-shifted cruxhalorhodopsin. (a) Red
light photocurrents (left y-axis, red bars) and photocurrent densities (right y-axis, white bars)
from cruxhalorhodopsins and the N. pharaonis halorhodopsin in cultured neurons (632 nm,
5 mW/mm2; n = 6 cells for each). ATCC, American Type Culture Collection; DSM,
German Collection of Microorganisms and Cell Cultures. (b) The K200R W214F Halo57
mutant (n = 9 cells) demonstrates enhanced photocurrents over wild-type Halo57 in cultured
neurons (n = 10 cells; 632 nm, 5 mW/mm2). (c) Photocurrents (black bars) and photocurrent
densities (white bars) for wild-type Halo57 (n = 9 cells), Halo57 (K200R W214F) (n = 21
cells), Jaws (n = 11 cells) and Jaws-ER2 in cultured neurons (n = 5 cells; 5 mW/mm2, 543
nm; P < 0.01 for all variants compared to the wild-type Halo57). (d) Action spectra for Jaws
(n = 12 cells), ArchT (n = 13 cells) and eNpHR3.0 (n = 15 cells; measured in cultured
neurons using equal photon fluxes of ~3.0 × 1021 photons s−1 m−2). (e) Red:green
photocurrent ratios for Jaws (n = 33 cells), ArchT (n = 36 cells) and eNpHR3.0 in cultured
neurons (n = 29 cells; 5 mW/mm2 at 632 nm or 543 nm). Regression lines are shown for
each opsin, indicating distinct spectral shifts. (f) Red-light mediated photocurrents (left y-
axis, red bars) and photocurrent densities (right y-axis, white bars) for Jaws (n = 33 cells),
ArchT (n = 36 cells) and eNpHR3.0 in cultured neurons (n = 29 cells; 5 mW/mm2 at 632
nm; P < 0.001 for Jaws compared to ArchT or eNpHR3.0). Data in each panel were
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measured from 2 batches of neuron culture. Values throughout are mean ± s.e.m. In b, *P =
0.020; in c, from left to right, **P = 0.0017, **P = 0.0047, *P = 0.0183; in f, ***P < 0.001.
Unpaired t-tests in b, ANOVA in c with Dunnett’s post hoc test using wild-type Halo57 as
the reference, ANOVA in f with Newman-Keuls post hoc test. t = 2.567 for b; F = 5.473 for
c and 14.02 for f.
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Figure 2.
Jaws-mediated light responses in mouse retinitis pigmentosa retinas. (a) Confocal
fluorescence images from Jaws-GFP expressing retina with the fast form of retinal
degeneration (f-RD), stained for GFP (green) and mouse cone arrestin (mCAR) (magenta), 4
weeks after injection with AAV8-mCAR-Jaws-GFP virus. Scale bar, 20 µm. (b) Raw traces
recorded from ON and OFF retinal ganglion cells in retinas expressing Jaws in cone
photoreceptors, optically stimulated with 9.6 × 1017 photons cm−2 s−1 at 600 nm for 1 s. (c)
Comparison of mean spiking in ganglion cells downstream of neurons expressing eNpHR (n
= 21 cells from 1 mouse), Halo57 (n = 14 cells from 1 mouse), ArchT (n = 30 cells from 1
mouse), Mac (n = 13 cells from 2 mice) or Jaws (n = 27 cells from 1 mouse) at opsin peak
wavelength sensitivity. Light intensity was 1.2 × 1018 photons cm−2 s−1 for green light
(ArchT, Mac) and 9.6 × 1017 photons cm−2 s−1 for red light (Jaws, eNpHR, Halo57). Dotted
line indicates baseline f-RD firing per ref. 49. (d) Population distribution of retinal ganglion
cell peak firing rates at opsin peak wavelength sensitivity. Light intensities as indicated in c;
dotted lines indicate the minimum (minWT) and maximum (maxWT) of the wild-type
dynamic range24. (e) Retinal ganglion spike rate versus red, green and blue irradiances,
measured in ganglion cells downstream of opsin-expressing cones in f-RD retina. Values are
means ± s.e.m.; n values for c–e are as indicated in c. In c–e, ***P < 0.001, *P < 0.0001.
ANOVAs in c,e with Dunnett’s post hoc test using eNpHR as the reference; Kolmogorov-
Smirnov test in d. F = 22.13 for c and 37.08, 32.53 and 10.43 for e. In c, ****P < 0.0001 for
Jaws, ***P < 0.001 for ArchT, P = 0.9973 for Halo57 and P = 0.4929 for Mac. In d, as
compared to Jaws, P < 0.0001 for eNpHR, P < 0.0001 for Halo57, P = 0.0375 for ArchT
and P = 0.0008 for Mac. In eP = 0.4679, P = 0.001, P < 0.0001, P < 0.0001 for green and P
= 0.2703, P = 0.001, P < 0.0001 and P < 0.0001 for red, from lowest to highest irradiance.
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Figure 3.
Jaws-mediated inhibition of evoked responses in visual cortex. (a) Representative rasters of
visually evoked responses (top left) and Jaws-mediated inhibition of visually evoked
responses (top right), and post-stimulus time histograms for visually evoked (bottom left)
and Jaws-inhibited visually evoked (bottom right) responses, of a representative neuron (n =
27) in the visual cortex of an anesthetized Emx1-cre mouse, as measured by extracellular
tetrode recording (AAV5-FLEX virus; 35 mW/mm2 at 593 nm using a 200-µm fiber). (b)
Population average of five simultaneously recorded neurons showing visually evoked
responses (left) and Jaws-mediated inhibition of visually evoked responses (right). (c)
Inhibition of visually evoked neural responses for eNpHR (n = 8 units from 2 mice),
eNpHR3.0 (n = 32 units from 4 mice), Arch (n = 18 units from 3 mice), ArchT (n = 21 units
from 3 mice) and Jaws (n = 27 units from 4 mice; P < 0.01 for Jaws versus eNpHR3.0). (d)
Jaws-mediated inhibition of visually evoked responses (n = 14 units from 2 mice) for
different visual input stimulus strengths. (e) Comparison of spontaneous and immediately
post-illumination firing rates for Jaws, eNpHR3.0 and ArchT (n = 32 units from 4 mice for
eNpHR3.0, n = 21 units from 3 mice for ArchT, n = 5 units for Jaws from 2 mice; P < 0.05
for Jaws versus eNpHR3.0). (f) Post-stimulus time histogram for a standard, step light pulse
(black line) versus ramped illumination (yellow line), for a spontaneously firing visual
cortex neuron. (g,h) Comparison of peak firing rates (g) and rebound delay rates (h) for step
versus ramped illumination (n = 16 units from 3 mice). Values throughout are mean ± s.e.m.
For c,e,g,h, *P < 0.05, **P < 0.01, ***P < 0.001. ANOVAs with Newman-Keuls post hoc
tests in c,e; paired t-tests in g,hF = 7.379 for c, 2.826 for e; t = 4.485 for g and 9.078 for h.
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Figure 4.
Jaws-mediated red light inhibition in rodent cortex. (a) Confocal fluorescence images from
Jaws-GFP–expressing motor cortex, 6 weeks after injection. Outline indicates brain
boundary50. Scale bar, 1 mm (top) or 100 µm (bottom). (b) Representative current-clamp
recording of Jaws-expressing neuron undergoing optically evoked (top, 632 nm, 5
mW/mm2) or electrically evoked (bottom) hyperpolarization in acute cortical slice 6 weeks
after injection. Red bar indicates optical illumination; blue trace indicates electrical current
injection. (c) Quantification of Jaws photocurrents as a function of red light irradiance in
acute slice (n = 16 cells from 4 mice). (d) Confocal fluorescence images of Jaws-GFP-,
Jaws-GFP-ER2- or eNpHR3.0-expressing motor cortex. Scale bars, 100 µm. (e) Side-by-
side comparison of red light–driven inhibition of spontaneous neural activity in motor cortex
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(n = 6 units from 2 mice for each opsin; light powers were measured at the tip of a 200-µm
fiber; 637 nm). (f) Red-light inhibition was equivalent to yellow-light inhibition for Jaws (n
= 5 units from 2 mice; P = 0.4685) and Jaws-ER2 (n = 6 units from 2 mice; P = 0.1952), but
substantially less potent for eNpHR3.0 (n = 6 units from 2 mice; P = 0.0121). (g) Red light
efficaciously inhibited neurons expressing Jaws (n = 5 units from 2 mice) and Jaws-ER2 (n
= 6 units from 2 mice) but not eNpHR3.0 (n = 8 units from 2 mice) over a range of firing
rates. Values throughout are mean ± s.e.m. In e,f, n.s., not significant; *P < 0.05, **P <
0.01, ***P < 0.001, ****P < 0.0001. Unpaired t-test in e, paired t-test in f. From left to
right, t = 0.2902, 3.264, 3.494, 2.422, 5.422, 11.4, 9.275 and 4.338 for e and 0.6205, 3.843
and 1.496 for f. In eP = 0.031, 0.0068, 0.0452, 0.0016, <0.0001, <0.0001 and 0.0025 from
lowest to highest irradiance. In fP = 0.4685 for Jaws, P = 0.1952 for Jaws-ER2 and *P =
0.0121 for eNpHR3.0.
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Figure 5.
Noninvasive red-light inhibition of neural activity. (a) Schematic of noninvasive red light
delivery through the intact skull. (b,c) Fluorescence images from mouse insular cortex (b;
scale bar, 1 mm) and motor cortex (c; scale bars, 25 µm) 6 weeks after injection with AAV8-
hSyn-Jaws virus. Outline indicates brain boundary50. (d) Raster plot (top) and population
average (bottom) of transdural inhibition of neurons in the medial prefrontal cortex of
anesthetized mice, showing light-induced suppression 6–8 weeks after injection with AAV8-
hSyn-Jaws virus (n = 26 units from 2 mice; red bar, 1 s pulse, 25 mW/mm2 fiber tip
irradiance, 635 nm). Red bars denote red light illumination. Vertical red lines in f also
demarcate the illumination period. (e) Representative glass-pipette extracellular recording (n
= 13) of a transcranially illuminated cortical neuron 2,700 µm below the brain surface in an
awake mouse (red bar, 10 mW/mm2 fiber tip irradiance, 635 nm; 4 weeks after injection
with AAV8-hSyn-Jaws virus). (f) Spike rasters taken from a representative neuron (top) and
population average (bottom; n = 13 units from 6 mice) of instantaneous firing rate in
neurons from awake mice undergoing transcranial light-induced suppression 4–8 weeks
after injection with AAV8-hSyn-Jaws virus (5 s pulse, 10 mW/mm2 635 nm fiber tip
irradiance; black line, mean; gray lines, mean ± s.e.m.). (g) Percentage reduction in neural
activity for neurons recorded at different depths in awake mouse brain, 6–8 weeks after
injection with AAV8-hSyn-Jaws virus. Red light delivered via traditional 200-µm fiber (n =
37 units from 11 mice) or transcranially (n = 13 units from 6 mice). (h) Firing rate averaged
over the illumination period versus baseline firing rate for neurons recorded in awake mouse
brain (n = 37 units from 11 mice for 200-µm-fiber illumination; n = 13 units from 6 mice for
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transcranial illumination; n = 14 units from 5 mice for transcranial illumination of non-
opsin-expressing neurons). (i) Representative extracellular recordings of neurons 1,800 µm
(top) and 1,300 µm (bottom) below the surface of the awake brain undergoing illumination
via a 200-µm fiber (red bar, ~130 mW/mm2, 635 nm) 500 µm above the electrode tip (left)
or transcranially (right) through the intact skull (~10 mW/mm2; 635 nm), recorded 8 weeks
after injection with AAV8-hSyn-Jaws virus. (j) Transcranial and 200-µm-fiber illumination
were equally efficacious (left) in inhibiting neurons (n = 8 units from 6 mice; P = 0.5894;
n.s., not significant) over depths of up to 3 mm (right). Values are means ± s.e.m. Paired t-
test in j t = 0.5655.
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